Primary mucinous adenocarcinoma of the vulva: A case report and review of the literature

Primary vulvar cancer is a rare disease with an incidence of 2-3 per 100,000 women. The vast majority of vulvar carcinomas are of the squamous cell type (90%). Primary vulvar adenocarcinomas rank among the rare gynecological malignancies. We herein present a case of a vulvar mass near the vaginal or...

Full description

Saved in:
Bibliographic Details
Published in:Molecular and clinical oncology 2016-04, Vol.4 (4), p.545-548
Main Authors: SUI, YANXIA, ZOU, JUNKAI, BATCHU, NASRA, LV, SHULAN, SUN, CHAO, DU, JIANG, WANG, QING, SONG, QING, LI, QILING
Format: Article
Language:English
Subjects:
Adenocarcinoma
Antigens
Biopsy
Cancer therapies
Care and treatment
Case reports
Case studies
Chemotherapy
Diagnosis
Dissection
Genital cancers
Gynecology
Lymphatic system
management
Metastasis
Morbidity
Obstetrics
Oncology
Patients
Pruritus
Surgery
Surgical outcomes
Tomography
Tumors
vulvar carcinoma
Vulvar diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c574t-909391a124c408b0ea08d3e78430f34cafe8f580b209cd9f31a847c2c277d1033
cites cdi_FETCH-LOGICAL-c574t-909391a124c408b0ea08d3e78430f34cafe8f580b209cd9f31a847c2c277d1033
container_end_page 548
container_issue 4
container_start_page 545
container_title Molecular and clinical oncology
container_volume 4
creator SUI, YANXIA
ZOU, JUNKAI
BATCHU, NASRA
LV, SHULAN
SUN, CHAO
DU, JIANG
WANG, QING
SONG, QING
LI, QILING
description Primary vulvar cancer is a rare disease with an incidence of 2-3 per 100,000 women. The vast majority of vulvar carcinomas are of the squamous cell type (90%). Primary vulvar adenocarcinomas rank among the rare gynecological malignancies. We herein present a case of a vulvar mass near the vaginal orifice, the biopsy of which revealed a mucinous adenocarcinoma. Local excision was performed, followed by postoperative chemotherapy. The patient was asymptomatic and developed no recurrence during the 2 years of follow-up after surgery and chemotherapy. We consider local excision, with or without chemotherapy, to be an effective therapeutic approach to this type of tumor. However, further studies are required to support our conclusions for early-stage vulvar mucinous adenocarcinoma.
doi_str_mv 10.3892/mco.2016.766
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4812100</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A451229158</galeid><sourcerecordid>A451229158</sourcerecordid><originalsourceid>FETCH-LOGICAL-c574t-909391a124c408b0ea08d3e78430f34cafe8f580b209cd9f31a847c2c277d1033</originalsourceid><addsrcrecordid>eNptkstv1DAQhy0EolXpjTOKBAcOZBm_EpsD0mrFSyoqB5C4WV5n3LpK4sVOFvHf42jbhSI8B4_tb37WPAh5SmHFlWavBxdXDGizapvmATllIHStRaMfHn0JJ-Q85xsoS7fApH5MTlgLLW-kPiXfv6Qw2PSrGmYXxjjnynY4RmfTchxsFX01XWO1n_u9fVOtK2czVgl3MU2VHbvi7gP-vMP6MGGy05zwCXnkbZ_x_HY_I9_ev_u6-VhfXH74tFlf1E62Yqo1aK6ppUw4AWoLaEF1HFslOHgunPWovFSwZaBdpz2nVonWMcfatqPA-Rl5e9DdzdsBO4fjlGxvdoe0TLTB3H8Zw7W5insjFGUUoAi8vBVI8ceMeTJDyA773o5Y6mGoYk3TSKlZQZ__g97EOY0lPUM1Z6XWQtI_1JXt0YTRx_KvW0TNurwzpqlUhVr9hyrW4RBcHNGHcn8v4NUhwKWYc0J_zJGCWYbBlGEwyzCYMgwFf_Z3XY7wXesL8OIA5F3pY-hiPjKfN5c1FFt0fgP-2bnv</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1932450451</pqid></control><display><type>article</type><title>Primary mucinous adenocarcinoma of the vulva: A case report and review of the literature</title><source>PubMed Central</source><creator>SUI, YANXIA ; ZOU, JUNKAI ; BATCHU, NASRA ; LV, SHULAN ; SUN, CHAO ; DU, JIANG ; WANG, QING ; SONG, QING ; LI, QILING</creator><creatorcontrib>SUI, YANXIA ; ZOU, JUNKAI ; BATCHU, NASRA ; LV, SHULAN ; SUN, CHAO ; DU, JIANG ; WANG, QING ; SONG, QING ; LI, QILING</creatorcontrib><description>Primary vulvar cancer is a rare disease with an incidence of 2-3 per 100,000 women. The vast majority of vulvar carcinomas are of the squamous cell type (90%). Primary vulvar adenocarcinomas rank among the rare gynecological malignancies. We herein present a case of a vulvar mass near the vaginal orifice, the biopsy of which revealed a mucinous adenocarcinoma. Local excision was performed, followed by postoperative chemotherapy. The patient was asymptomatic and developed no recurrence during the 2 years of follow-up after surgery and chemotherapy. We consider local excision, with or without chemotherapy, to be an effective therapeutic approach to this type of tumor. However, further studies are required to support our conclusions for early-stage vulvar mucinous adenocarcinoma.</description><identifier>ISSN: 2049-9450</identifier><identifier>EISSN: 2049-9469</identifier><identifier>DOI: 10.3892/mco.2016.766</identifier><identifier>PMID: 27073659</identifier><language>eng</language><publisher>England: D.A. Spandidos</publisher><subject>Adenocarcinoma ; Antigens ; Biopsy ; Cancer therapies ; Care and treatment ; Case reports ; Case studies ; Chemotherapy ; Diagnosis ; Dissection ; Genital cancers ; Gynecology ; Lymphatic system ; management ; Metastasis ; Morbidity ; Obstetrics ; Oncology ; Patients ; Pruritus ; Surgery ; Surgical outcomes ; Tomography ; Tumors ; vulvar carcinoma ; Vulvar diseases</subject><ispartof>Molecular and clinical oncology, 2016-04, Vol.4 (4), p.545-548</ispartof><rights>Copyright © 2016, Spandidos Publications</rights><rights>COPYRIGHT 2016 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2016</rights><rights>Copyright © 2016, Spandidos Publications 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c574t-909391a124c408b0ea08d3e78430f34cafe8f580b209cd9f31a847c2c277d1033</citedby><cites>FETCH-LOGICAL-c574t-909391a124c408b0ea08d3e78430f34cafe8f580b209cd9f31a847c2c277d1033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812100/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812100/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27073659$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SUI, YANXIA</creatorcontrib><creatorcontrib>ZOU, JUNKAI</creatorcontrib><creatorcontrib>BATCHU, NASRA</creatorcontrib><creatorcontrib>LV, SHULAN</creatorcontrib><creatorcontrib>SUN, CHAO</creatorcontrib><creatorcontrib>DU, JIANG</creatorcontrib><creatorcontrib>WANG, QING</creatorcontrib><creatorcontrib>SONG, QING</creatorcontrib><creatorcontrib>LI, QILING</creatorcontrib><title>Primary mucinous adenocarcinoma of the vulva: A case report and review of the literature</title><title>Molecular and clinical oncology</title><addtitle>Mol Clin Oncol</addtitle><description>Primary vulvar cancer is a rare disease with an incidence of 2-3 per 100,000 women. The vast majority of vulvar carcinomas are of the squamous cell type (90%). Primary vulvar adenocarcinomas rank among the rare gynecological malignancies. We herein present a case of a vulvar mass near the vaginal orifice, the biopsy of which revealed a mucinous adenocarcinoma. Local excision was performed, followed by postoperative chemotherapy. The patient was asymptomatic and developed no recurrence during the 2 years of follow-up after surgery and chemotherapy. We consider local excision, with or without chemotherapy, to be an effective therapeutic approach to this type of tumor. However, further studies are required to support our conclusions for early-stage vulvar mucinous adenocarcinoma.</description><subject>Adenocarcinoma</subject><subject>Antigens</subject><subject>Biopsy</subject><subject>Cancer therapies</subject><subject>Care and treatment</subject><subject>Case reports</subject><subject>Case studies</subject><subject>Chemotherapy</subject><subject>Diagnosis</subject><subject>Dissection</subject><subject>Genital cancers</subject><subject>Gynecology</subject><subject>Lymphatic system</subject><subject>management</subject><subject>Metastasis</subject><subject>Morbidity</subject><subject>Obstetrics</subject><subject>Oncology</subject><subject>Patients</subject><subject>Pruritus</subject><subject>Surgery</subject><subject>Surgical outcomes</subject><subject>Tomography</subject><subject>Tumors</subject><subject>vulvar carcinoma</subject><subject>Vulvar diseases</subject><issn>2049-9450</issn><issn>2049-9469</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNptkstv1DAQhy0EolXpjTOKBAcOZBm_EpsD0mrFSyoqB5C4WV5n3LpK4sVOFvHf42jbhSI8B4_tb37WPAh5SmHFlWavBxdXDGizapvmATllIHStRaMfHn0JJ-Q85xsoS7fApH5MTlgLLW-kPiXfv6Qw2PSrGmYXxjjnynY4RmfTchxsFX01XWO1n_u9fVOtK2czVgl3MU2VHbvi7gP-vMP6MGGy05zwCXnkbZ_x_HY_I9_ev_u6-VhfXH74tFlf1E62Yqo1aK6ppUw4AWoLaEF1HFslOHgunPWovFSwZaBdpz2nVonWMcfatqPA-Rl5e9DdzdsBO4fjlGxvdoe0TLTB3H8Zw7W5insjFGUUoAi8vBVI8ceMeTJDyA773o5Y6mGoYk3TSKlZQZ__g97EOY0lPUM1Z6XWQtI_1JXt0YTRx_KvW0TNurwzpqlUhVr9hyrW4RBcHNGHcn8v4NUhwKWYc0J_zJGCWYbBlGEwyzCYMgwFf_Z3XY7wXesL8OIA5F3pY-hiPjKfN5c1FFt0fgP-2bnv</recordid><startdate>20160401</startdate><enddate>20160401</enddate><creator>SUI, YANXIA</creator><creator>ZOU, JUNKAI</creator><creator>BATCHU, NASRA</creator><creator>LV, SHULAN</creator><creator>SUN, CHAO</creator><creator>DU, JIANG</creator><creator>WANG, QING</creator><creator>SONG, QING</creator><creator>LI, QILING</creator><general>D.A. Spandidos</general><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160401</creationdate><title>Primary mucinous adenocarcinoma of the vulva: A case report and review of the literature</title><author>SUI, YANXIA ; ZOU, JUNKAI ; BATCHU, NASRA ; LV, SHULAN ; SUN, CHAO ; DU, JIANG ; WANG, QING ; SONG, QING ; LI, QILING</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c574t-909391a124c408b0ea08d3e78430f34cafe8f580b209cd9f31a847c2c277d1033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adenocarcinoma</topic><topic>Antigens</topic><topic>Biopsy</topic><topic>Cancer therapies</topic><topic>Care and treatment</topic><topic>Case reports</topic><topic>Case studies</topic><topic>Chemotherapy</topic><topic>Diagnosis</topic><topic>Dissection</topic><topic>Genital cancers</topic><topic>Gynecology</topic><topic>Lymphatic system</topic><topic>management</topic><topic>Metastasis</topic><topic>Morbidity</topic><topic>Obstetrics</topic><topic>Oncology</topic><topic>Patients</topic><topic>Pruritus</topic><topic>Surgery</topic><topic>Surgical outcomes</topic><topic>Tomography</topic><topic>Tumors</topic><topic>vulvar carcinoma</topic><topic>Vulvar diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SUI, YANXIA</creatorcontrib><creatorcontrib>ZOU, JUNKAI</creatorcontrib><creatorcontrib>BATCHU, NASRA</creatorcontrib><creatorcontrib>LV, SHULAN</creatorcontrib><creatorcontrib>SUN, CHAO</creatorcontrib><creatorcontrib>DU, JIANG</creatorcontrib><creatorcontrib>WANG, QING</creatorcontrib><creatorcontrib>SONG, QING</creatorcontrib><creatorcontrib>LI, QILING</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular and clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SUI, YANXIA</au><au>ZOU, JUNKAI</au><au>BATCHU, NASRA</au><au>LV, SHULAN</au><au>SUN, CHAO</au><au>DU, JIANG</au><au>WANG, QING</au><au>SONG, QING</au><au>LI, QILING</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary mucinous adenocarcinoma of the vulva: A case report and review of the literature</atitle><jtitle>Molecular and clinical oncology</jtitle><addtitle>Mol Clin Oncol</addtitle><date>2016-04-01</date><risdate>2016</risdate><volume>4</volume><issue>4</issue><spage>545</spage><epage>548</epage><pages>545-548</pages><issn>2049-9450</issn><eissn>2049-9469</eissn><abstract>Primary vulvar cancer is a rare disease with an incidence of 2-3 per 100,000 women. The vast majority of vulvar carcinomas are of the squamous cell type (90%). Primary vulvar adenocarcinomas rank among the rare gynecological malignancies. We herein present a case of a vulvar mass near the vaginal orifice, the biopsy of which revealed a mucinous adenocarcinoma. Local excision was performed, followed by postoperative chemotherapy. The patient was asymptomatic and developed no recurrence during the 2 years of follow-up after surgery and chemotherapy. We consider local excision, with or without chemotherapy, to be an effective therapeutic approach to this type of tumor. However, further studies are required to support our conclusions for early-stage vulvar mucinous adenocarcinoma.</abstract><cop>England</cop><pub>D.A. Spandidos</pub><pmid>27073659</pmid><doi>10.3892/mco.2016.766</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2049-9450
ispartof Molecular and clinical oncology, 2016-04, Vol.4 (4), p.545-548
issn 2049-9450
2049-9469
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4812100
source PubMed Central
subjects Adenocarcinoma
Antigens
Biopsy
Cancer therapies
Care and treatment
Case reports
Case studies
Chemotherapy
Diagnosis
Dissection
Genital cancers
Gynecology
Lymphatic system
management
Metastasis
Morbidity
Obstetrics
Oncology
Patients
Pruritus
Surgery
Surgical outcomes
Tomography
Tumors
vulvar carcinoma
Vulvar diseases
title Primary mucinous adenocarcinoma of the vulva: A case report and review of the literature
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T03%3A09%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20mucinous%20adenocarcinoma%20of%20the%20vulva:%20A%20case%20report%20and%20review%20of%20the%20literature&rft.jtitle=Molecular%20and%20clinical%20oncology&rft.au=SUI,%20YANXIA&rft.date=2016-04-01&rft.volume=4&rft.issue=4&rft.spage=545&rft.epage=548&rft.pages=545-548&rft.issn=2049-9450&rft.eissn=2049-9469&rft_id=info:doi/10.3892/mco.2016.766&rft_dat=%3Cgale_pubme%3EA451229158%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c574t-909391a124c408b0ea08d3e78430f34cafe8f580b209cd9f31a847c2c277d1033%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1932450451&rft_id=info:pmid/27073659&rft_galeid=A451229158&rfr_iscdi=true